Does $760 m a year of industry funding affect the FDA's drug approval process?
Wolfe, S.M.
Bmj 349: G5012
2014
ISSN/ISBN: 0959-8138 PMID: 25096994 Document Number: 676775
Document emailed within 1 workday
Related Documents
Cohen, M.H.; Johnson, J.R.; Pazdur, R. 2005: U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(1): 12-19Gifford, R.W. 1980: The FDA new drug approval process Connecticut Medicine 44(5): 309-311
1993: FDA issues regulations on accelerated drug-approval process Clinical Pharmacy 12(4): 253-254
Anderson, L.F. 1989: Cancer and AIDS groups push for changes in drug approval process Journal of the National Cancer Institute 81(11): 829-831
Fredd, S.B. 1990: The OTC drug approval process. The ACG Committee on FDA-Related Matters. American College of Gastroenterology American Journal of Gastroenterology 85(1): 12-14
Browne, T.R. 1993: Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods Epilepsy Research. Suppl 10: 31-44
Zierenberg, O. 1997: Approval of drugs by national and European agencies--sequelae for the pharmaceutical industry Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 91(7): 596-600
Astrup, K.G.; Riis, P. 1995: Drug approval. Orientation from the drug department of the National Board of Health and Welfare and the scientific-ethical committee system Ugeskrift for Laeger 157(46): 6442-6443
Robinson, D.S. 1994: Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. a pharmaceutical industry perspective on drug labeling Psychopharmacology Bulletin 30(1): 23-25
Coussins, J. 1999: Should industry sponsor research? Portman Group has always openly acknowledged its source of funding Bmj 318(7178): 261
Chren, M.M. 1994: Independent investigators and for-profit companies. Guidelines for biomedical scientists considering funding by industry Archives of Dermatology 130(4): 432-437
Stribling, J.H. 1992: What's holding up animal drug approval? Journal of the American Veterinary Medical Association 200(12): 1806-1808
Otsuka, Y. 2012: Drug approval lag in Japan and drugs for children No to Hattatsu 44(1): 2
Morrow, T. 2015: A Rare Approval. FDA OKs Pediatric Cancer Drug Managed Care 24(10): 42-43
1991: Pre-approval inspections/investigations. Food and Drug Administration Journal of parenteral science and technology: a publication of the Parenteral Drug Association 45(1): 56-66
Kahn, L.G. 1998: Research resources for aquaculture drug development and approval Veterinary and Human Toxicology 40(Suppl 2): 41-43
Logachev, I.G. 1977: Medical equipment industry in the 1st year of the 10th Five-Year Plan Meditsinskaia Tekhnika 1977(3): 3-5
Crooks, A. 2005: How does ageing affect the wound healing process? Journal of Wound Care 14(5): 222-223
Candy, D.C. 1999: Should industry sponsor research? Funding of research by infant formula companies Bmj 318(7178): 260
Niimi, S. 2015: Development of guidance for the approval process of brand-new medical products and regenerative medicine products Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku 133: 1-7